Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
Status:
Completed
Trial end date:
2018-08-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of delafloxacin compared to
moxifloxacin in the treatment of adult patients with community-acquired pneumonia.
Phase:
Phase 3
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Anti-Bacterial Agents Fluoroquinolones Linezolid Moxifloxacin Norgestimate, ethinyl estradiol drug combination